Measuring Serum Melatonin in Epidemiologic Studies
Authors:
- 1 April 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (4) , 932-937
Abstract
Background: Epidemiologic data on serum melatonin, a marker of circadian rhythms, and cancer are sparse due largely to the lack of reliable assays with high sensitivity to detect relatively low melatonin levels in serum collected during daylight, as commonly available in most epidemiologic studies. Methods: To help expand epidemiologic research on melatonin, we assessed the reproducibility and refined a currently available melatonin RIA, and evaluated its application to epidemiologic investigations by characterizing melatonin levels in serum, urine, and/or plasma in 135 men from several ethnic groups. Results: Reproducibility was high for the standard 1.0-mL serum [mean coefficient of variation (CV), 6.9%; intraclass correlation coefficient (ICC), 97.4%; n = 2 serum pools in triplicate] and urine-based (mean CV, 3.5%; ICC, 99.9%) assays. Reproducibility for the 0.5-mL refined-serum assay was equally good (mean CV, 6.6%; ICC, 99.0%). There was a positive correlation between morning serum melatonin and 6-sulfatoxymelatonin in 24-hour urine (r = 0.46; P = 0.008; n = 49 subjects). Melatonin levels in serum-plasma pairs had a high correlation (r = 0.97; P < 1×10−4; n = 20 pairs). Morning serum melatonin levels were five times higher than those from the afternoon (before 9 a.m. mean, 11.0 pg/mL, versus after 11 a.m. mean, 2.0 pg/mL). Chinese men had lower melatonin levels (mean, 3.4 pg/mL), whereas Caucasian, African-American, and Ghanaian men had similar levels (mean, 6.7-8.6 pg/mL). Conclusions: These results suggest that melatonin can be detected reliably in serum samples collected in epidemiologic studies in various racial groups. Impact: With improved assays, it may be possible to investigate the role of melatonin and the emerging circadian rhythm hypothesis in cancer etiology in epidemiologic studies. Cancer Epidemiol Biomarkers Prev; 19(4); 932–7. ©2010 AACR.Keywords
This publication has 31 references indexed in Scilit:
- Clock-Cancer Connection in Non–Hodgkin's Lymphoma: A Genetic Association Study and Pathway Analysis of the Circadian Gene Cryptochrome 2Cancer Research, 2009
- Sleep duration and the risk of breast cancer: the Ohsaki Cohort StudyBritish Journal of Cancer, 2008
- Sleep duration and the risk of prostate cancer: the Ohsaki Cohort StudyBritish Journal of Cancer, 2008
- Sleep duration, melatonin and breast cancer among Chinese women in SingaporeCarcinogenesis, 2008
- Variants in circadian genes and prostate cancer risk: a population-based study in ChinaProstate Cancer and Prostatic Diseases, 2007
- Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer riskBreast Cancer Research and Treatment, 2007
- Low testosterone levels and unimpaired melatonin secretion in young males with metabolic syndromeAndrologia, 2006
- Ala394Thr polymorphism in the clock gene NPAS2: A circadian modifier for the risk of non‐Hodgkin's lymphomaInternational Journal of Cancer, 2006
- Night work and breast cancer risk: A systematic review and meta-analysisEuropean Journal of Cancer, 2005
- Altered melatonin secretion in hypogonadal men: clinical evidenceInternational Journal of Andrology, 2005